Literature DB >> 29971645

Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy.

Pavan Parikh1, Lori Blauwet2.   

Abstract

PURPOSE OF REVIEW: Hypertensive disorders of pregnancy (HDP) often result in cardiac dysfunction and have been variably included as a risk factor for peripartum cardiomyopathy (PPCM). However, there is debate regarding the relationship between the two entities. RECENT
FINDINGS: Diastolic dysfunction appears to be more predominant among gravidas with HDP, while systolic dysfunction predominates in PPCM. However, this finding is not consistent in all studies. Recent examinations of mortality and morbidity associated with PPCM in the setting of HDP do not demonstrate a predominant pattern with a mixture of results. Further, right ventricular dysfunction is identified to be a common theme in both populations. From a basic science perspective, there is evidence to demonstrate a predominantly anti-angiogenic milieu in both PPCM and HDP. PPCM and HDP associated cardiomyopathy overlap significantly. As such, unifying theories for their pathophysiology should be investigated.

Entities:  

Keywords:  Cardiomyopathy; Heart failure; Hypertension; Peripartum; Preeclampsia; Pregnancy

Mesh:

Year:  2018        PMID: 29971645     DOI: 10.1007/s11906-018-0868-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  60 in total

1.  Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti.

Authors:  James D Fett; Robert D Carraway; Duane L Dowell; Mary Etta King; Ronald Pierre
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

2.  Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy.

Authors:  Olaf Forster; Denise Hilfiker-Kleiner; Aftab A Ansari; J Bruce Sundstrom; Elena Libhaber; Winnie Tshani; Anthony Becker; Anthony Yip; Gunnar Klein; Karen Sliwa
Journal:  Eur J Heart Fail       Date:  2008-09-02       Impact factor: 15.534

3.  Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.

Authors:  Lori A Blauwet; Antonia Delgado-Montero; Keiko Ryo; Josef J Marek; Rami Alharethi; Paul J Mather; Kalgi Modi; Richard Sheppard; Vinay Thohan; Jessica Pisarcik; Dennis M McNamara; John Gorcsan
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

4.  Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.

Authors:  James D Fett; Len G Christie; Robert D Carraway; Joseph G Murphy
Journal:  Mayo Clin Proc       Date:  2005-12       Impact factor: 7.616

5.  Haemodynamics in women with untreated pre-eclampsia.

Authors:  A T Dennis; J Castro; C Carr; S Simmons; M Permezel; C Royse
Journal:  Anaesthesia       Date:  2012-06-26       Impact factor: 6.955

6.  Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-.

Authors:  Chizuko A Kamiya; Masafumi Kitakaze; Hatsue Ishibashi-Ueda; Satoshi Nakatani; Toyoaki Murohara; Hitonobu Tomoike; Tomoaki Ikeda
Journal:  Circ J       Date:  2011-05-27       Impact factor: 2.993

7.  Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.

Authors:  Melanie Ricke-Hoch; Insa Bultmann; Britta Stapel; Gianluigi Condorelli; Ursula Rinas; Karen Sliwa; Michaela Scherr; Denise Hilfiker-Kleiner
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

8.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

9.  Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia.

Authors:  Alfredo Leaños-Miranda; Inova Campos-Galicia; Karla Leticia Ramírez-Valenzuela; Zarela Lizbeth Chinolla-Arellano; Irma Isordia-Salas
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

Review 10.  Oxidative Stress in Preeclampsia and Placental Diseases.

Authors:  Rajaa Aouache; Louise Biquard; Daniel Vaiman; Francisco Miralles
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

View more
  5 in total

Review 1.  Stroke in Pregnancy: A Focused Update.

Authors:  Eliza C Miller; Lisa Leffert
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

2.  Racial Differences in Postpartum Blood Pressure Trajectories Among Women After a Hypertensive Disorder of Pregnancy.

Authors:  Alisse Hauspurg; Lara Lemon; Camila Cabrera; Amal Javaid; Anna Binstock; Beth Quinn; Jacob Larkin; Andrew R Watson; Richard H Beigi; Hyagriv Simhan
Journal:  JAMA Netw Open       Date:  2020-12-01

Review 3.  The Relationship Between Peripartum Cardiomyopathy and Preeclampsia - Pathogenesis, Diagnosis and Management.

Authors:  Aleksandra Kuć; Daria Kubik; Klaudia Kościelecka; Wojciech Szymanek; Tomasz Męcik-Kronenberg
Journal:  J Multidiscip Healthc       Date:  2022-04-23

4.  Pre-pregnancy Obesity and the Risk of Peripartum Cardiomyopathy.

Authors:  Seo-Ho Cho; Stephanie A Leonard; Audrey Lyndon; Elliott K Main; Barbara Abrams; Afshan B Hameed; Suzan L Carmichael
Journal:  Am J Perinatol       Date:  2020-06-08       Impact factor: 3.079

5.  A Case-Control Study of Peripartum Cardiomyopathy Using the Rochester Epidemiology Project.

Authors:  Erika J Douglass; Leslie T Cooper; A Carolina Morales-Lara; Demilade A Adedinsewo; Todd D Rozen; Lori A Blauwet; Delisa Fairweather
Journal:  J Card Fail       Date:  2021-01-01       Impact factor: 5.712

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.